Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 12, 2012 - Issue 10
Submit an article Journal homepage
891
Views
43
CrossRef citations to date
0
Altmetric
Reviews

Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration

Ciro CostagliolaDipartimento di Scienze per la Salute, Cattedra di Oculistica, Università degli Studi del Molise, Campobasso, Italy
,
Luca AgnifiliDipartimento di Medicina e Scienze dell'Invecchiamento, Clinica Oculistica, Università degli Studi G. d'Annunzio di Chieti-Pescara, Chieti, Italy
,
Barbara ArcidiaconoDipartimento di Specialità Chirurgiche, Scienze Radiologiche e Medico Forensi, Clinica Oculistica, Università degli Studi di Brescia, Brescia, Italy
,
Sarah DuseDipartimento di Specialità Chirurgiche, Scienze Radiologiche e Medico Forensi, Clinica Oculistica, Università degli Studi di Brescia, Brescia, Italy
,
Vincenzo FasanellaDipartimento di Medicina e Scienze dell'Invecchiamento, Clinica Oculistica, Università degli Studi G. d'Annunzio di Chieti-Pescara, Chieti, Italy
,
Rodolfo MastropasquaDipartimento di Scienze Neurologiche, Neuropsicologiche, Morfologiche e Motorie, Clinica Oculistica, Università degli Studi di Verona, Verona, Italy
,
Marco VerolinoDipartimento di Scienze per la Salute, Cattedra di Oculistica, Università degli Studi del Molise, Campobasso, Italy
&
Francesco SemeraroDipartimento di Specialità Chirurgiche, Scienze Radiologiche e Medico Forensi, Clinica Oculistica, Università degli Studi di Brescia, Brescia, Italy;Professor, Clinica Oculistica, Università degli Studi di Brescia, P.le Spedali Civili, 1 - 25123 Brescia, [email protected]
, MD show all
Pages 1299-1313 | Published online: 07 Aug 2012

Citations (43)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Anne-Mette Hvas, Emmanuel J Favaloro & Maja Hellfritzsch. (2021) Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment. Expert Review of Hematology 14:4, pages 335-346.
Read now
Andreas Katsanos, Kostantina Gorgoli, Dimitrios G. Mikropoulos, Esther Arranz-Marquez, Georgios P. Athanasopoulos, Miguel A. Teus & Anastasios G.P. Konstas. (2018) Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma. Expert Opinion on Biological Therapy 18:6, pages 719-724.
Read now
Yuka Ito, Yoshitsugu Saishin, Osamu Sawada, Masashi Kakinoki, Taichiro Miyake, Tomoko Sawada, Hajime Kawamura & Masahito Ohji. (2015) Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion. Clinical Ophthalmology 9, pages 175-180.
Read now
Zuohuizi Yi, Changzheng Chen, Yu Su, Lu Li & Yunyun Zhou. (2015) Changes in Clotting Time, Plasma Fibrinogen Levels, and Blood Viscosity After Administration of Ranibizumab for Treatment of Choroidal Neovascularization. Current Eye Research 40:11, pages 1166-1171.
Read now
Francesco Semeraro, Andrea Russo, Elena Gambicorti, Sarah Duse, Francesco Morescalchi, Sara Vezzoli & Ciro Costagliola. (2015) Efficacy and vitreous levels of topical NSAIDs. Expert Opinion on Drug Delivery 12:11, pages 1767-1782.
Read now
Sascha Meyer dos Santos, Karina Kuczka, Bettina Picard-Willems, Karen Nelson, Ute Klinkhardt & Sebastian Harder. (2015) The integrin antagonist, cilengitide, is a weak inhibitor of αIIbβ3 mediated platelet activation and inhibits platelet adhesion under flow. Platelets 26:1, pages 59-66.
Read now
Saba Hashemi, Mohammad Ali Faramarzi, Khalil Ghasemi Falavarjani & Mohammad Abdollahi. (2014) Bevacizumab for choroidal neovascularization secondary to age-related macular degeneration and pathological myopia. Expert Opinion on Biological Therapy 14:12, pages 1837-1848.
Read now
Francesco Semeraro, Francesco Morescalchi, Sarah Duse, Elena Gambicorti, Mario R Romano & Ciro Costagliola. (2014) Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview. Expert Opinion on Drug Safety 13:6, pages 785-802.
Read now
Michael Thomas, Shaymaa S Mousa & Shaker A Mousa. (2013) Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration. Clinical Ophthalmology 7, pages 495-501.
Read now
F Semeraro, F Morescalchi, S Duse, F Parmeggiani, E Gambicorti & C Costagliola. (2013) Aflibercept in wet AMD: specific role and optimal use. Drug Design, Development and Therapy 7, pages 711-722.
Read now

Articles from other publishers (33)

Sara Aly Attia & J. Andrew MacKay. (2022) Protein and polypeptide mediated delivery to the eye. Advanced Drug Delivery Reviews 188, pages 114441.
Crossref
Lin YangPeng YuMei ChenBo Lei. (2022) Mammalian Target of Rapamycin Inhibitor Rapamycin Alleviates 7-Ketocholesterol Induced Inflammatory Responses and Vascular Endothelial Growth Factor Elevation by Regulating MAPK Pathway in Human Retinal Pigment Epithelium Cells. Journal of Ocular Pharmacology and Therapeutics 38:2, pages 189-200.
Crossref
Bhim B. Rai, Rohan W. Essex, Faran Sabeti, Ted Maddess, Emilie M. F. Rohan, Joshua P. van Kleef & Corinne F. Carle. (2021) An Objective Perimetry Study of Central Versus Peripheral Sensitivities and Delays in Age-Related Macular Degeneration. Translational Vision Science & Technology 10:14, pages 24.
Crossref
Ayah Mohammad Burhan, Butsabarat Klahan, Wayne Cummins, Vanessa Andrés-Guerrero, Mark E. Byrne, Niall J. O’Reilly, Anuj Chauhan, Laurence Fitzhenry & Helen Hughes. (2021) Posterior Segment Ophthalmic Drug Delivery: Role of Muco-Adhesion with a Special Focus on Chitosan. Pharmaceutics 13:10, pages 1685.
Crossref
Sean T. Berkowitz & Shriji Patel. (2021) Value of Anti–Vascular Endothelial Growth Factor Gene Therapy for Neovascular Age-Related Macular Degeneration. Ophthalmology Retina 5:4, pages 357-364.
Crossref
Zois Papadopoulos. (2020) Recent Developments in the Treatment of Wet Age-related Macular Degeneration. Current Medical Science 40:5, pages 851-857.
Crossref
Yusuke Arai, Hidenori Takahashi, Satoru Inoda, Shinichi Sakamoto, Xue Tan, Yuji Inoue, Satoko Tominaga, Hidetoshi Kawashima & Yasuo Yanagi. (2020) Efficacy of Modified Treat-and-Extend Aflibercept Regimen for Macular Edema Due to Branch Retinal Vein Occlusion: 1-Year Prospective Study. Journal of Clinical Medicine 9:8, pages 2360.
Crossref
Xiaolei Sun, Jingjing Zhang, Jingyi Tian, Shijiu Chen, Fanxing Zeng & Gongqiang Yuan. (2020) Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis. Journal of Ophthalmology 2020, pages 1-8.
Crossref
Jing Cao, Rong Yang, Taylor E. Smith, Stephanie Evans, Gary W. McCollum, Steven C. Pomerantz, Theodore Petley, Ian R. Harris & John S. Penn. (2019) Human Umbilical Tissue-Derived Cells Secrete Soluble VEGFR1 and Inhibit Choroidal Neovascularization. Molecular Therapy - Methods & Clinical Development 14, pages 37-46.
Crossref
Zois Papadopoulos. (2019) Aflibercept: A review of its effect on the treatment of exudative age-related macular degeneration. European Journal of Ophthalmology 29:4, pages 368-378.
Crossref
Benjamin Batteux, Valérie Gras, Yanis Mahboud, Sophie Liabeuf, Youssef Bennis & Kamel Masmoudi. (2019) Ischaemic colitis associated with intravitreal administration of aflibercept: A first case report. British Journal of Clinical Pharmacology 85:4, pages 845-848.
Crossref
B. Sobolewska, J. Golenko, S. Poeschel, C. Grimmel, A. Gatsiou, K. Sopova, T. Biedermann, K. Schenke-Layland, K. Stellos & F. Ziemssen. (2018) Influence of aflibercept on platelet activation profile. Experimental Eye Research 175, pages 166-172.
Crossref
R. Attal, I. Lazareth, G. Angelopoulos & P. Priollet. (2018) Ranibizumab and digital ischemia. JMV-Journal de Médecine Vasculaire 43:1, pages 65-69.
Crossref
Anu Vaajanen & Heikki Vapaatalo. (2017) A Single Drop in the Eye – Effects on the Whole Body?. The Open Ophthalmology Journal 11:1, pages 305-314.
Crossref
Stacy HuSteven Koevary. (2016) Efficacy of Antibody Delivery to the Retina and Optic Nerve by Topical Administration. Journal of Ocular Pharmacology and Therapeutics 32:4, pages 203-210.
Crossref
Young Gun Park & Young-Jung Roh. (2016) New Diagnostic and Therapeutic Approaches for Preventing the Progression of Diabetic Retinopathy. Journal of Diabetes Research 2016, pages 1-9.
Crossref
Stefan Koinzer, Jan Heckmann, Jan Tode & Johann Roider. (2015) Long-term, therapy-related visual outcome of 49 cases with retinal arterial macroaneurysm: a case series and literature review. British Journal of Ophthalmology 99:10, pages 1345-1353.
Crossref
Gökhan Pekel, Semra Acer, Ebru Nevin Çetin, Ramazan Yağcı, Alper Kaşıkçı & Ali Çevik. (2014) Ocular pulse amplitude and retinal vessel caliber changes after intravitreal ranibizumab. International Ophthalmology 35:5, pages 657-662.
Crossref
Noemi Manresa, Juana Mulero, Manuel Losada & Pilar Zafrilla. (2015) EFFECT OF PEGAPTANIB AND RANIBIZUMAB ON PLASMA AND VITREOUS HOMOCYSTEINE IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION. Retina 35:9, pages 1765-1771.
Crossref
J. Thorel, E. Civade, J. C. Quintyn, P. Cestac, J.-L. Montastruc & H. Bagheri. (2015) Ischaemic stroke after exposure to aflibercept: interaction with vitamin K antagonist and/or direct pharmacodynamic effect?. Journal of Clinical Pharmacy and Therapeutics 40:4, pages 477-479.
Crossref
HONGZOO PARK, DAE-SUNG LEE, MI-JIN YIM, YUNG HYUN CHOI, SAEGWANG PARK, SU-KIL SEO, JUNG SIK CHOI, WON HEE JANG, SUNG SU YEA, WON SUN PARK, CHANG-MIN LEE, WON-KYO JUNG & IL-WHAN CHOI. (2015) 3,3′-Diindolylmethane inhibits VEGF expression through the HIF-1α and NF-κB pathways in human retinal pigment epithelial cells under chemical hypoxic conditions. International Journal of Molecular Medicine 36:1, pages 301-308.
Crossref
F. Semeraro, A. Cancarini, F. Morescalchi, M.R. Romano, R. dell’Omo, G. Ruggeri, L. Agnifili & C. Costagliola. (2014) Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy. Diabetes & Metabolism 40:6, pages 445-451.
Crossref
Sara Rezzola, Mirella Belleri, Giuseppina Gariano, Domenico Ribatti, Ciro Costagliola, Francesco Semeraro & Marco Presta. (2013) In vitro and ex vivo retina angiogenesis assays. Angiogenesis 17:3, pages 429-442.
Crossref
Szilárd Kiss, Ying Liu, Joseph Brown, Nancy M. Holekamp, Arghavan Almony, Joanna Campbell & Jonathan W. Kowalski. (2014) Clinical Monitoring of Patients With Age-Related Macular Degeneration Treated With Intravitreal Bevacizumab or Ranibizumab. Ophthalmic Surgery, Lasers and Imaging Retina 45:4, pages 285-291.
Crossref
Patrick Paulus, Johannes Holfeld, Bertram Scheller, Kai Zacharowski, Christin Reissig, Elisabeth Tybl, Pia Alexandra Ockelmann & Anja Urbschat. (2014) VEGF-A Blockade Reduces Reperfusion Edema but Favors Arterial Thromboembolism in a Rat Model of Orthotopic Lung Transplantation. Transplantation 97:9, pages 908-916.
Crossref
Nancy M. Holekamp, Ying Liu, Wei-Shi Yeh, Yifeng Chia, Szilárd Kiss, Arghavan Almony & Jonathan W. Kowalski. (2014) Clinical Utilization of Anti-VEGF Agents and Disease Monitoring in Neovascular Age-Related Macular Degeneration. American Journal of Ophthalmology 157:4, pages 825-833.e1.
Crossref
Wei-Xiang Qi, Zan Shen, Li-Na Tang & Yang Yao. (2014) Risk of Hypertension in Cancer Patients Treated with Aflibercept: A Systematic Review and Meta-Analysis. Clinical Drug Investigation 34:4, pages 231-240.
Crossref
Giuseppe TridenteGiuseppe Tridente. 2014. Adverse Events with Biomedicines. Adverse Events with Biomedicines 335 350 .
A Guzman-Aranguez, P Loma & J Pintor. (2013) Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy. British Journal of Pharmacology 170:4, pages 730-747.
Crossref
Miriam E. JaaxKrystin Krauel, Thomas MarschallSven Brandt, Julia Gansler, Birgitt FürllBettina AppelSilvia Fischer, Stephan Block, Christiane A. Helm, Sabine MüllerKlaus T. Preissner & Andreas Greinacher. (2013) Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4. Blood 122:2, pages 272-281.
Crossref
Sara Rezzola, Mirella Belleri, Domenico Ribatti, Ciro Costagliola, Marco Presta & Francesco Semeraro. (2013) A novel ex?vivo murine retina angiogenesis (EMRA) assay. Experimental Eye Research 112, pages 51-56.
Crossref
Robert J. Campbell, Chaim M. Bell, Erica de L.P. Campbell & Sudeep S. Gill. (2013) Systemic effects of intravitreal vascular endothelial growth factor inhibitors. Current Opinion in Ophthalmology 24:3, pages 197-204.
Crossref
Shaker A. Mousa. 2013. Angiogenesis Modulations in Health and Disease. Angiogenesis Modulations in Health and Disease 157 172 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.